Cat. No.: X24-08-YM219
Microtubule/Tubulin inhibitor, Vinflunine tartrate, Purity ≥98%
Synonym: 1201898-17-0; (2R,3R)-2,3-Dihydroxybutanedioic acid; (2R,3R)-2,3-Dihydroxybutanedioic acid; methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-4-[(12S,14R,16R)-16-(1,1-difluoroethyl)-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- CAS Number: 1201898-17-0
- Compound CID: 53245637
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
Vinflunine tartrate is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin. It targets the microtubules.
Molecular Formula
C45H54F2N4O8·xC4H6O6
Targets
Microtubules: 1.2 μM
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Vinflunine tartrate is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of various cancers, including advanced or metastatic transitional cell carcinoma of the bladder and other solid tumors.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%
